Enanta Pharmaceuticals
ENTA
#7475
Rank
HK$3.04 B
Marketcap
HK$104.96
Share price
-5.36%
Change (1 day)
85.83%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$1.69 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total liabilities are HK$1.69 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enanta Pharmaceuticals - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-09-30HK$1.68 B-12.75%
2024-09-30HK$1.92 B0.2%
2023-09-30HK$1.92 B352.97%
2022-09-30HK$0.42 B38.51%
2021-09-30HK$0.30 B29.44%
2020-09-30HK$0.23 B10.5%
2019-09-30HK$0.21 B33.21%
2018-09-30HK$0.16 B-17.49%
2017-09-30HK$0.19 B121.62%
2016-09-30HK$87.96 M15.16%
2015-09-30HK$76.37 M45.5%
2014-09-30HK$52.49 M4.05%
2013-09-30HK$50.44 M-20.97%
2012-09-30HK$63.83 M97.81%
2011-09-30HK$32.26 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
HK$920.98 B 54,371.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$504.06 B 29,712.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
HK$1.068 T 63,088.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$59.04 B 3,392.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$607.68 B 35,841.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$559.88 B 33,014.37%๐Ÿ‡บ๐Ÿ‡ธ USA